Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion. Issue 1 (27th April 2015)

• Record Type: Journal Article
• Authors: Rijken, J.A.; Niemeijer, N.D.; Corssmit, E.P.M.; Jonker, M.A.; Leemans, C.R.; Menko, F.H.; Hensen, E.F.
• Is Part Of: Clinical genetics. Volume 89:Issue 1(2016)
• Page Start: 128
• Page End: 132
• Publication Date: 2015-04-27
• Subjects: hereditary -- paragangliomas -- penetrance -- pheochromocytomas -- SDHB; Medical genetics -- Periodicals; 616.0420
• DOI: 10.1111/cge.12591
• Languages: English
• ISSNs: 0009-9163

Abstract

Abstract : In the Netherlands, the majority of hereditary paragangliomas (PGL) is caused by SDHD, SDHB and SDHAF2 mutations. Founder mutations in SDHD are particularly prevalent, but several SDHB founder mutations have also been described. Here, we describe an extended PGL family with a Dutch founder mutation in SDHB, c.201‐4429_287‐933del. The proband presented with apparently sporadic head and neck paraganglioma at advanced age. Subsequently, evaluation of the family identified several unaffected mutation carriers, asymptomatic and symptomatic PGL patients, and patients presenting with early‐onset malignant pheochromocytoma. The calculated penetrance of the SDHB mutation in this kindred is lower than the risk suggested for SDHB mutations in the literature. This may represent a characteristic of this particular SDHB mutation, but may also be a reflection of the inclusion of relatively large numbers of asymptomatic mutation carriers in this family and adequate statistical correction for ascertainment bias. The low penetrance of SDHB mutations may obscure the hereditary nature of SDHB‐linked disease and is important in the counseling of SDHB‐linked patients. Risk estimates should preferably be based on the specific mutation involved.